Loading
Latest filing published 15 Dec 2023 for IN8BIO, INC..
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Trishna Goswami discloses dealings in In8bio, Inc. to SEC (Form 4). Between 16 August 2022 and 13 December 2023, the trades on record add up to 2 filings.
The open-market record is one-sided, with 1 purchase worth €4,915 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant.
On 15 December 2023 came the latest disclosure, a share grant in In8bio, Inc. The last insider purchase was made public on 18 August 2022, 1,528 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations